Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DW-1401 in Acute and Chronic Gastritis
NCT03443804Phase 3Completed
- Sponsor
- Daewon Pharm
- Start
- Jul 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of DW-1401 in acute gastritis and chronic gastritis (2 arms), sponsored by Daewon Pharm. Primary endpoint: Efficacy rate on gastroscopy at 2 weeks. Started Jul 2014; status: completed.
02
Drugs
DW-1401
03
Conditions
acute gastritischronic gastritis
Beyond the preview
Go deeper on NCT03443804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03443804.